Recent advances in natriuretic peptides in congestive heart failure

被引：69
作者：
Boerrigter, G [1 ]
Burnett, JC [1 ]
机构：
[1] Coll Med, Mayo Clin, Rochester, MN 55905 USA
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2004年 / 13卷 / 06期
关键词：
cyclic guanosine monophosphate; heart failure; natriuretic pepticles; nesiritide; neurohumoral activation;
D O I：
10.1517/13543784.13.6.643
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are secreted by the heart and play important roles in the compensation of congestive heart failure with their vasodilating, natriuretic, antiproliferative, lusitropic and neurohumoral-modulating properties. Based on these beneficial properties, exogenous BNP was developed as a new treatment for congestive heart failure and approved in the US for acute decompensated heart failure. New therapeutic strategies for heart failure that are currently being investigated include chronic subcutaneous BNP administration and intermittent BNP infusions. Furthermore, strategies combining exogenous BNP with an inhibitor of the BNP-degrading enzyme neutral endopeptidase could contribute to maximising the actions of BNP and reduce the amount of exogenous BNP needed.
引用
收藏
页码：643 / 652
页数：10
相关论文
共 58 条
[1]  
Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1
[2]   EFFECTS OF BRAIN NATRIURETIC PEPTIDE ON RENIN SECRETION IN NORMAL AND HYPERTONIC SALINE-INFUSED KIDNEY [J].
AKABANE, S ;
MATSUSHIMA, Y ;
MATSUO, H ;
KAWAMURA, M ;
IMANISHI, M ;
OMAE, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 198 (2-3) :143-148
[3]   Intravenous Nesiritide (Human B-Type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure [J].
Aronson, D ;
Burger, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) :435-+
[4]  
BAYLISS J, 1987, BRIT HEART J, V57, P17
[5]  
Boerrigter G, 2003, CIRCULATION, V108, P398
[6]   Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure [J].
Boerrigter, G ;
Costello-Boerrigter, LC ;
Cataliotti, A ;
Tsuruda, T ;
Harty, GJ ;
Lapp, H ;
Stasch, JP ;
Burnett, JC .
CIRCULATION, 2003, 107 (05) :686-689
[7]   Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects [J].
Brunner-La Rocca, HP ;
Kaye, DM ;
Woods, RL ;
Hastings, J ;
Esler, MD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1221-1227
[8]   Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].
Burger, AJ ;
Horton, DP ;
LeJemtel, T ;
Ghali, JK ;
Torre, G ;
Dennish, G ;
Koren, M ;
Dinerman, J ;
Silver, M ;
Cheng, ML ;
Elkayam, U .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108
[9]   Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure [J].
Cataliotti, A ;
Boerrigter, G ;
Costello-Boerrigter, LC ;
Schirger, JA ;
Tsuruda, T ;
Heublein, DM ;
Chen, HH ;
Malatino, LS ;
Burnett, JC .
CIRCULATION, 2004, 109 (13) :1680-1685
[10]   Mapping of DNA markers to arms and sub-arm regions of Nicotiana sylvestris chromosomes using aberrant alien addition lines [J].
Chen, CC ;
Chen, SK ;
Liu, MC ;
Kao, YY .
THEORETICAL AND APPLIED GENETICS, 2002, 105 (01) :8-15
123456